Leslie Tari

This profile gathers the share dealings of Leslie Tari in Cidara Therapeutics, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 30 September 2021 to 11 March 2025, the count stands at 14 filings.

On the open market, the record shows 1 purchase worth €8,891 and 8 sales worth €112k. Taken together, the sales exceed the purchases by €103k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants and 1 option exercise. 2025 to date brings no purchases and 1 sale.

The latest filing, published on 13 March 2025, reports an open-market sale of €36k in Cidara Therapeutics, Inc. The clock since the last published purchase (14 August 2023) now reads 1,183 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.